PTB Pascolizumab

This is a randomized, double-blind, placebo-controlled, proof of concept clinical trial to assess the safety and…

A phase II/III multicenter, open-label, multicohort, two-part study evaluating the pharmacokinetics (PK), safety, and antiviral activity of Elvitegravir (EVG) administered with a background regimen (BR) containing a Ritonavir-boosted protease inhibitor (PI/r) in HIV-1 infected, antiretroviral treatment-experienced pediatric subjects

This is an open-label, multicenter, multicohort, two-part study to confirm the dose and evaluate the safety…

HIV reservoir in early-treated children

This is a cross-sectional study of clinical data and blood sample collection for HIV reservoir and…

The latent HIV reservoir in early treated Thai children

This is a prospective observational study that will characterize the HIV reservoir size and replication, and…

HIV-NAT 238

This is a phase2/3, open-label study of the pharmacokinetics, safety, and antiviral activity of the GS-9883/Emtricitabine/tenofovir…

Evaluating pharmacokinetics interactions with vaginal ring contraceptive and ART

This study will look at a method of hormonal birth control, called the NuvaRing, and specific…

Natural history of hepatitis C infection, clinical significances, prognostic factors and treatment outcome/toxicity among Thai HIV-infected patients with chronic hepatitis

This is a cohort study that will use questionnaires and collect specimens/samples to assess the natural…

Efficacy of Tenofovir Alafenamide versus placebo added to a failing regimen followed by treatment with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Atazanavir in HIV-1 positive, antiretroviral treatment-experienced adults

This is a phase III, two part study to evaluate the efficacy of Tenofovir Alafenamide versus…

Phase II multiple ascending dose proof of concept study

This is a phase IIa, randomized, open-label, ascending, sequential dose group, multiple dose study of the…

A phase III, randomized, double-blind study to evaluate the safety and efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide versus Elvitegravir/Cobicistat/Emtricitabine/Tenofovir disoproxil fumarate in HIV-1 positive, antiretroviral treatment-naïve adults

Randomized, Double-Blind, multicenter, active-controlled study to evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/…